檢索結果 - Ari M. Vanderwalde

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Microsatellite instability status determined by next‐generation sequencing and compared with <scp>PD</scp>‐L1 and tumor mutational burden in 11,348 patients

    Microsatellite instability status determined by next‐generation sequencing and compared with <scp>PD</scp>‐L1 and tumor mutational burden in 11,348 patients 由 Ari M. Vanderwalde, David Spetzler, Nianqing Xiao, Zoran Gatalica, John L. Marshall

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers

    Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers 由 Kabir Mody, Jason S. Starr, Michelle Saul, Kelsey Poorman, Benjamin A. Weinberg, Mohamed E. Salem, Ari M. Vanderwalde, Anthony F. Shields

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database

    Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database 由 Jeff Owsley, Matthew K. Stein, Jason Porter, Gino K. In, Mohamed E. Salem, Steven O’Day, Andrew Elliott, Kelsey Poorman, Geoffrey T. Gibney, Ari M. Vanderwalde

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Racial Disparities in the Molecular Landscape of Cancer

    Racial Disparities in the Molecular Landscape of Cancer 由 Elisabeth I. Heath, Filipa Lynce, Joanne Xiu, Angela Ellerbrock, Sandeep K. Reddy, Elias Obeid, Stephen V. Liu, Aliccia Bollig‐Fischer, Duška Šeparović, Ari M. Vanderwalde

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes

    ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes 由 Favour A. Akinjiyan, George Nassief, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Alice Y. Zhou, George P. Souroullas, Kevin B. Kim, Ari M. Vanderwalde, Soo J. Park, George Ansstas

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Detection of NRG1 Gene Fusions in Solid Tumors

    Detection of NRG1 Gene Fusions in Solid Tumors 由 Sushma Jonna, Rebecca Feldman, Jeffrey Swensen, Zoran Gatalica, W. Michael Korn, Hossein Borghaei, C. Patrick, Jorge J. Nieva, Alexander I. Spira, Ari M. Vanderwalde, Antoinette J. Wozniak, Edward S. Kim, Stephen V. Liu

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies

    Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies 由 Ari M. Vanderwalde, C.-L. Sun, Lester Laddaran, Liton Francisco, Saro H. Armenian, Jennifer Berano-Teh, F. Lennie Wong, Leslie Popplewell, George Somlo, Anthony S. Stein, AP Nademanee, A. Krishnan, Neil Kogut, SJ Forman, Smita Bhatia

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

    Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study 由 Funda Meric‐Bernstam, Herbert I. Hurwitz, Kanwal Raghav, Robert R. McWilliams, Marwan Fakih, Ari M. Vanderwalde, Charles Swanton, Razelle Kurzrock, Howard A. Burris, Christopher J. Sweeney, Ron Bose, David R. Spigel, Mary Beattie, Steven Blotner, Alyssa Stone, Katja Schulze, Vaikunth Cuchelkar, John D. Hainsworth

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

    Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy 由 Antoni Ribas, Reinhard Dummer, Igor Puzanov, Ari M. Vanderwalde, Robert H.I. Andtbacka, Olivier Michielin, Anthony J. Olszanski, Josep Malvehy, Jonathan Cebon, Eugenio Fernández, John M. Kirkwood, Thomas F. Gajewski, Lisa Chen, Kevin Gorski, Abraham Anderson, Scott J. Diede, Michael E. Lassman, Jennifer Gansert, F. Stephen Hodi, Georgina V. Long

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

    Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy 由 Antoni Ribas, Reinhard Dummer, Igor Puzanov, Ari M. Vanderwalde, Robert H.I. Andtbacka, Olivier Michielin, Anthony J. Olszanski, Josep Malvehy, Jonathan Cebon, Eugenio Fernández, John M. Kirkwood, Thomas F. Gajewski, Lisa Chen, Kevin Gorski, Abraham Anderson, Scott J. Diede, Michael E. Lassman, Jennifer Gansert, F. Stephen Hodi, Georgina V. Long

    出版 2018
    獲取全文
    Errata/Corrigenda
    加到收藏夾
    Saved in:
  11. 11
    Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer

    Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer 由 Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M. Vanderwalde, Hirva Mamdani, Luis E. Raez, Misako Nagasaka, Sachin Gopalkrishna Pai, Mark A. Socinski, Jorge J. Nieva, Chul Kim, Antoinette J. Wozniak, Chukwuemeka Ikpeazu, Gilberto Lopes, Alexander I. Spira, W. Michael Korn, Edward S. Kim, Stephen V. Liu, Hossein Borghaei

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Pan-Cancer Interrogation of B7-H3 (<i>CD276</i>) as an Actionable Therapeutic Target Across Human Malignancies

    Pan-Cancer Interrogation of B7-H3 (<i>CD276</i>) as an Actionable Therapeutic Target Across Human Malignancies 由 Carly D. Miller, John R. Lozada, Nicholas A. Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I. Heath, Neeraj Agarwal, Rana R. McKay, Rohan Garje, Bruno R. Bastos, Dave S.�B. Hoon, Jacob J. Orme, Oliver Sartor, Ari M. Vanderwalde, Chadi Nabhan, George W. Sledge, Eugene Shenderov, Scott M. Dehm, Emil Lou, Jeffrey S. Miller, Justin H. Hwang, Emmanuel S. Antonarakis

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

    Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma 由 Jason Chesney, Antoni Ribas, Georgina V. Long, John M. Kirkwood, Reinhard Dummer, Igor Puzanov, Christoph Höeller, Thomas F. Gajewski, Ralf Gutzmer, Piotr Rutkowski, Lev Demidov, Petr Arenberger, Sang Joon Shin, Pier Francesco Ferrucci, Andrew Haydon, John Hyngstrom, Johannes V. van Thienen, Sebastian Haferkamp, Josep Malvehy, Bernardo L. Rapoport, Ari M. Vanderwalde, Scott J. Diede, James R. Anderson, Sheryl Treichel, Edward L. Chan, Sumita Bhatta, Jennifer Gansert, F. Stephen Hodi, Helen Gogas

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

    Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma 由 Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A. Delman, Lynn E. S̄pitler, Igor Puzanov, Sanjiv S. Agarwala, Mohammed Milhem, Lee D. Cranmer, Brendan D. Curti, Karl D. Lewis, Merrick I. Ross, Troy H. Guthrie, Gerald P. Linette, Gregory A. Daniels, Kevin J. Harrington, Mark R. Middleton, Wilson H. Miller, Jonathan S. Zager, Yining Ye, Bin Yao, Li Ai, Susan Doleman, Ari M. Vanderwalde, Jennifer Gansert, Robert S. Coffin

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

    Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial 由 Ari M. Vanderwalde, Shay Bellasea, Kari Kendra, Nikhil I. Khushalani, Katie M. Campbell, Philip O. Scumpia, Lawrence F. Kuklinski, Frances A. Collichio, Jeffrey A. Sosman, Alexandra P. Ikeguchi, Adrienne I. Victor, Thach‐Giao Truong, Bartosz Chmielowski, David C. Portnoy, Yuanbin Chen, Kim Margolin, Charles Bane, Constantin A Dasanu, Douglas B. Johnson, Zeynep Eroglu, Sunandana Chandra, Egmidio Medina, Cynthia R. Gonzalez, Ignacio Baselga-Carretero, Agustin Vega-Crespo, Ivan Perez Garcilazo, Elad Sharon, Siwen Hu‐Lieskovan, Sapna P. Patel, Kenneth F. Grossmann, James Moon, Michael C. Wu, Antoni Ribas

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors

    Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors 由 Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica Lee, Joao V. Alessi, Adriana Barrichello, Victor R. Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini Gandhi, Dimitris Gazgalis, William W. Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H. Gottlieb, Monica F. Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K. Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S. Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M. Vanderwalde, C. Patrick, Balázs Halmos, Stephen V. Liu, Jianwei Che, Alexa B. Schrock, Alexander Drilon, Pasi A. Jänne, Mark M. Awad

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: